Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1572 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

BRIEF COMMUNICATION

Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study

Philip Elizabeth, Sundaram Meenakshi L, Das Rupam, Chauhan Sushil Kumar, Deshpande Sandeep, Ambhore Sanjay, Rathod Rahul, Manjrekar Pravin

Year : 2013| Volume: 17| Issue : 9 | Page no: 674-679

   This article has been cited by
 
1 Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan
Huai Heng Loh,Nor Azmi Kamaruddin
Annals of the Academy of Medicine, Singapore. 2020; 49(7): 468
[Pubmed]  [Google Scholar] [DOI]
2 Antidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: In vivo approach
Venkatesan Amalan,Natesan Vijayakumar,Dhananjayan Indumathi,Arumugam Ramakrishnan
Biomedicine & Pharmacotherapy. 2016; 84: 230
[Pubmed]  [Google Scholar] [DOI]
3 Pu-erh tea polysaccharides decrease blood sugar by inhibition of a-glucosidase activity in vitro and in mice
Yea-Tyz Deng,Shoei-Yn Lin-Shiau,Lie-Fen Shyur,Jen-Kun Lin
Food Funct.. 2015; 6(5): 1539
[Pubmed]  [Google Scholar] [DOI]
4 Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes
Shashank R Joshi,Ambady Ramachandran,Manoj Chadha,Sudip Chatterjee,Rahul Rathod,Sanjay Kalra
Expert Opinion on Pharmacotherapy. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article